In vivo disruption of latent HSV by designer endonuclease therapy.
Aubert M, Madden EA, Loprieno M, DeSilva Feelixge HS, Stensland L, Huang ML, Greninger AL, Roychoudhury P, Niyonzima N, Nguyen T, Magaret A, Galleto R, Stone D, Jerome KR.
Aubert M, et al. Among authors: roychoudhury p.
JCI Insight. 2016 Sep 8;1(14):e88468. doi: 10.1172/jci.insight.88468.
JCI Insight. 2016.
PMID: 27642635
Free PMC article.